139 related articles for article (PubMed ID: 37204106)
1. Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.
Mau T; Amin MR; Belafsky PC; Best SR; Friedman AD; Klein AM; Lott DG; Paniello RC; Pransky SM; Saba NF; Howard T; Dallas M; Patel A; Morrow MP; Skolnik JM
Laryngoscope; 2023 Nov; 133(11):3087-3093. PubMed ID: 37204106
[TBL] [Abstract][Full Text] [Related]
2. Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.
Aggarwal C; Cohen RB; Morrow MP; Kraynyak KA; Sylvester AJ; Cheung J; Dickerson K; Schulten V; Knoblock D; Gillespie E; Bauml JM; Yan J; Diehl M; Boyer J; Dallas M; Kim JJ; Weiner DB; Skolnik JM
Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 32013270
[TBL] [Abstract][Full Text] [Related]
3. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
4. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
6. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.
James EA; DeVoti JA; Rosenthal DW; Hatam LJ; Steinberg BM; Abramson AL; Kwok WW; Bonagura VR
J Immunol; 2011 Jun; 186(11):6633-40. PubMed ID: 21531896
[TBL] [Abstract][Full Text] [Related]
8. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
Tjon Pian Gi RE; San Giorgi MR; Slagter-Menkema L; van Hemel BM; van der Laan BF; van den Heuvel ER; Dikkers FG; Schuuring EM
Head Neck; 2015 Nov; 37(11):1625-32. PubMed ID: 24955561
[TBL] [Abstract][Full Text] [Related]
9. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
10. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
[TBL] [Abstract][Full Text] [Related]
11. Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis.
Yamada S; Itoh T; Ikegami T; Imai A; Mochizuki D; Nakanishi H; Ishikawa R; Kita J; Nakamura Y; Takizawa Y; Okamura J; Noda Y; Iwashita T; Hariyama T; Suzuki M; Misawa K; Kawasaki H
Sci Rep; 2023 Apr; 13(1):5514. PubMed ID: 37024540
[TBL] [Abstract][Full Text] [Related]
12. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia.
Sanchez GI; Jaramillo R; Cuello G; Quintero K; Baena A; O'Byrne A; Reyes AJ; Santamaria C; Cuello H; Arrunategui A; Cortez A; Osorio G; Reina JC; Quint WG; Muñoz N
Head Neck; 2013 Feb; 35(2):229-34. PubMed ID: 22367608
[TBL] [Abstract][Full Text] [Related]
14. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
Nogueira RL; Küpper DS; do Bonfim CM; Aragon DC; Damico TA; Miura CS; Passos IM; Nogueira ML; Rahal P; Valera FCP
Clin Otolaryngol; 2021 Jan; 46(1):181-188. PubMed ID: 32869523
[TBL] [Abstract][Full Text] [Related]
15. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.
Vonderheide RH; Kraynyak KA; Shields AF; McRee AJ; Johnson JM; Sun W; Chintakuntlawar AV; Pawlicki J; Sylvester AJ; McMullan T; Samuels R; Kim JJ; Weiner D; Boyer JD; Morrow MP; Humeau L; Skolnik JM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34230114
[TBL] [Abstract][Full Text] [Related]
18. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
Laryngoscope; 2023 Oct; 133(10):2725-2733. PubMed ID: 36815602
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial somatic mutations and the lack of viral genomic variation in recurrent respiratory papillomatosis.
Hao Y; Ruiz R; Yang L; Neto AG; Amin MR; Kelly D; Achlatis S; Roof S; Bing R; Kannan K; Brown SM; Pei Z; Branski RC
Sci Rep; 2019 Nov; 9(1):16625. PubMed ID: 31719597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
